Algenis
21 September 2018
Algenis specializes in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases.
You may be interested in...
-
Save the Date for LAVCA ESG Awards; Vinci Partners Merged with Compass Creating USD50b AUM Asset Management Platform
-
Timing on Startup Fundraising; Is AI a Thing in LatAm?
-
Vinci Partners Deal Case; Mexico Infrastructure Partners and Mexican Government Acquires 55% Stake in Mexico’s Generation Plants for USD6.2b from Iberdrola
-
TozziniFreire Appoints Three New Partners
Brazil-based full-service firm TozziniFreire Advogados appointed new...